In quiet debut, Alzheimer’s drug finds questions, skepticism
The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Read moreThe first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Read more